Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site-dependent manner in gastrointestinal stromal tumours.

Bure I, Braun A, Kayser C, Geddert H, Schaefer IM, Cameron S, Ghadimi MB, Ströbel P, Werner M, Hartmann A, Wiemann S, Agaimy A, Haller F, Moskalev EA.

Int J Cancer. 2017 Dec 1;141(11):2296-2304. doi: 10.1002/ijc.30905. Epub 2017 Aug 30.

PMID:
28744850
2.

Epigenetic Regulation of CD133 in Gastrointestinal Stromal Tumors.

Geddert H, Braun A, Kayser C, Dimmler A, Faller G, Agaimy A, Haller F, Moskalev EA.

Am J Clin Pathol. 2017 May 1;147(5):515-524. doi: 10.1093/ajcp/aqx028.

PMID:
28398518
3.

SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.

Agaimy A, Hartmann A, Antonescu CR, Chiosea SI, El-Mofty SK, Geddert H, Iro H, Lewis JS Jr, Märkl B, Mills SE, Riener MO, Robertson T, Sandison A, Semrau S, Simpson RH, Stelow E, Westra WH, Bishop JA.

Am J Surg Pathol. 2017 Apr;41(4):458-471. doi: 10.1097/PAS.0000000000000797.

4.

Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis.

Dimmler A, Geddert H, Werner M, Faller G.

Virchows Arch. 2017 Apr;470(4):429-435. doi: 10.1007/s00428-017-2092-4. Epub 2017 Feb 20.

PMID:
28220299
5.

Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.

Merten L, Agaimy A, Moskalev EA, Giedl J, Kayser C, Geddert H, Schaefer IM, Cameron S, Werner M, Ströbel P, Hartmann A, Haller F.

Am J Clin Pathol. 2016 Dec;146(6):718-726. doi: 10.1093/ajcp/aqw193. Epub 2016 Dec 27.

PMID:
28028119
6.

Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.

Agaimy A, Bieg M, Michal M, Geddert H, Märkl B, Seitz J, Moskalev EA, Schlesner M, Metzler M, Hartmann A, Wiemann S, Michal M, Mentzel T, Haller F.

Am J Surg Pathol. 2017 Feb;41(2):195-203. doi: 10.1097/PAS.0000000000000752.

PMID:
27776010
7.

In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components.

Woischke C, Schaaf CW, Yang HM, Vieth M, Veits L, Geddert H, Märkl B, Stömmer P, Schaeffer DF, Frölich M, Blum H, Vosberg S, Greif PA, Jung A, Kirchner T, Horst D.

Mod Pathol. 2017 Jan;30(1):95-103. doi: 10.1038/modpathol.2016.150. Epub 2016 Sep 2.

8.

Recurrent mutations within the amino-terminal region of β-catenin are probable key molecular driver events in sinonasal hemangiopericytoma.

Haller F, Bieg M, Moskalev EA, Barthelmeß S, Geddert H, Boltze C, Diessl N, Braumandl K, Brors B, Iro H, Hartmann A, Wiemann S, Agaimy A.

Am J Pathol. 2015 Feb;185(2):563-71. doi: 10.1016/j.ajpath.2014.10.019. Epub 2014 Dec 4.

PMID:
25482924
9.

Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor.

Haller F, Zhang JD, Moskalev EA, Braun A, Otto C, Geddert H, Riazalhosseini Y, Ward A, Balwierz A, Schaefer IM, Cameron S, Ghadimi BM, Agaimy A, Fletcher JA, Hoheisel J, Hartmann A, Werner M, Wiemann S, Sahin O.

Int J Cancer. 2015 Mar 1;136(5):1013-23. doi: 10.1002/ijc.29088. Epub 2014 Aug 1.

10.

Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.

Berger F, Geddert H, Faller G, Werner M, Dimmler A.

Pathol Res Pract. 2014 Sep;210(9):596-602. doi: 10.1016/j.prp.2014.05.006. Epub 2014 May 22.

PMID:
24954139
11.

Phenotypical and molecular distinctness of sinonasal haemangiopericytoma compared to solitary fibrous tumour of the sinonasal tract.

Agaimy A, Barthelmeß S, Geddert H, Boltze C, Moskalev EA, Koch M, Wiemann S, Hartmann A, Haller F.

Histopathology. 2014 Nov;65(5):667-73. doi: 10.1111/his.12452. Epub 2014 Aug 4.

PMID:
24807787
12.

EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix.

Dimmler A, Geddert H, Faller G.

Pathol Res Pract. 2014 May;210(5):274-8. doi: 10.1016/j.prp.2014.01.002. Epub 2014 Jan 31.

PMID:
24560515
13.

Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features.

Barthelmeß S, Geddert H, Boltze C, Moskalev EA, Bieg M, Sirbu H, Brors B, Wiemann S, Hartmann A, Agaimy A, Haller F.

Am J Pathol. 2014 Apr;184(4):1209-1218. doi: 10.1016/j.ajpath.2013.12.016. Epub 2014 Feb 8.

PMID:
24513261
14.

EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.

Fichter CD, Timme S, Braun JA, Gudernatsch V, Schöpflin A, Bogatyreva L, Geddert H, Faller G, Klimstra D, Tang L, Hauschke D, Werner M, Lassmann S.

Int J Cancer. 2014 Oct 1;135(7):1517-30. doi: 10.1002/ijc.28771. Epub 2014 Apr 2.

15.

Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).

Agaimy A, Otto C, Braun A, Geddert H, Schaefer IM, Haller F.

Int J Clin Exp Pathol. 2013 Aug 15;6(9):1839-46. eCollection 2013.

16.

STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.

Timme S, Ihde S, Fichter CD, Waehle V, Bogatyreva L, Atanasov K, Kohler I, Schöpflin A, Geddert H, Faller G, Klimstra D, Tang L, Reinheckel T, Hauschke D, Busch H, Boerries M, Werner M, Lassmann S.

Oncogene. 2014 Jun 19;33(25):3256-66. doi: 10.1038/onc.2013.298. Epub 2013 Aug 5.

PMID:
23912451
17.

High EpCAM expression is linked to proliferation and lauren classification in gastric cancer.

Kroepil F, Dulian A, Vallböhmer D, Geddert H, Krieg A, Vay C, Topp SA, am Esch JS, Baldus SE, Gires O, Knoefel WT, Stoecklein NH.

BMC Res Notes. 2013 Jul 5;6:253. doi: 10.1186/1756-0500-6-253.

18.

[Maxillary ameloblastoma extending into the sinonasal tract].

Geddert H, Runge S, Werner U, Walendzik H, Dimmler A.

Pathologe. 2013 Jul;34(4):335-7. doi: 10.1007/s00292-013-1753-6. German.

PMID:
23436120
19.

Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification.

Warth A, Cortis J, Fink L, Fisseler-Eckhoff A, Geddert H, Hager T, Junker K, Kayser G, Kitz J, Länger F, Morresi-Hauf A, Ott G, Petersen I, Stenzinger A, Soltermann A, Ting S, Tischler V, Vollmer E, Schnabel PA, Weichert W; Pulmonary Pathology Working Group of the German Society of Pathology.

Virchows Arch. 2012 Aug;461(2):185-93. Epub 2012 Jun 23.

PMID:
22729141
20.

Images in clinical medicine. Ectopic Cushing's syndrome.

Flohr F, Geddert H.

N Engl J Med. 2011 Dec 22;365(25):e46. doi: 10.1056/NEJMicm1010540. No abstract available.

21.

EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Geddert H, zur Hausen A, Gabbert HE, Sarbia M.

Cell Oncol (Dordr). 2011 Jun;34(3):209-14. doi: 10.1007/s13402-011-0028-6. Epub 2011 May 3.

PMID:
21538028
22.

EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.

Geddert H, Zur Hausen A, Gabbert HE, Sarbia M.

Anal Cell Pathol (Amst). 2010;33(3):143-9. doi: 10.3233/ACP-CLO-2010-0540.

23.

Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers.

Rohrbeck A, Neukirchen J, Rosskopf M, Pardillos GG, Geddert H, Schwalen A, Gabbert HE, von Haeseler A, Pitschke G, Schott M, Kronenwett R, Haas R, Rohr UP.

J Transl Med. 2008 Nov 7;6:69. doi: 10.1186/1479-5876-6-69.

24.

[Prognostic and predictive impact of protein expression profiling in high risk breast cancer patients treated with high-dose chemotherapy].

Diallo-Danebrock R, Ting E, Gluz O, Herr A, Mohrmann S, Geddert H, Gabbert HE, Nitz U, Poremba C.

Verh Dtsch Ges Pathol. 2007;91:187-96. German.

PMID:
18314614
25.

C-kit expression in high-risk breast cancer subgroup treated with high-dose or conventional dose-dense chemotherapy.

Diallo R, Ting E, Gluz O, Herr A, Schütt G, Geddert H, Mohrmann S, Gabbert HE, Nitz U, Poremba C.

Verh Dtsch Ges Pathol. 2006;90:177-85.

PMID:
17867595
26.
27.

Differentiation between pancreaticobiliary and upper gastrointestinal adenocarcinomas: is analysis of cytokeratin 17 expression helpful?

Sarbia M, Fritze F, Geddert H, von Weyhern C, Rosenberg R, Gellert K.

Am J Clin Pathol. 2007 Aug;128(2):255-9.

PMID:
17638659
28.

Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy.

Diallo-Danebrock R, Ting E, Gluz O, Herr A, Mohrmann S, Geddert H, Rody A, Schaefer KL, Baldus SE, Hartmann A, Wild PJ, Burson M, Gabbert HE, Nitz U, Poremba C.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):488-97.

29.

Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.

Rehfeld N, Geddert H, Atamna A, Gabbert HE, Steidl U, Fenk R, Kronenwett R, Haas R, Rohr UP.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2232-8.

30.

Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel.

Brücher BL, Geddert H, Langner C, Höfler H, Fink U, Siewert JR, Sarbia M.

Int J Cancer. 2006 Sep 15;119(6):1298-302.

31.

Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.

Grote HJ, Schmiemann V, Geddert H, Bocking A, Kappes R, Gabbert HE, Sarbia M.

Cancer. 2006 Apr 25;108(2):129-34.

32.

C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.

Diallo R, Rody A, Jackisch C, Ting E, Schaefer KL, Kissler S, Karn T, Geddert H, Engels K, Kaufmann M, Gabbert HE, Shroyer KR, Poremba C.

Hum Pathol. 2006 Feb;37(2):205-11.

PMID:
16426921
33.

The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.

Rehfeld N, Geddert H, Atamna A, Rohrbeck A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R, Gabbert HE, Kronenwett R, Haas R, Rohr UP.

J Carcinog. 2006 Jan 20;5:4. doi: 10.1186/1477-3163-5-4.

34.

Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.

Wethkamp N, Ramp U, Geddert H, Schulz WA, Florl AR, Suschek CV, Hassan M, Gabbert HE, Mahotka C.

Eur J Cancer. 2006 Jan;42(2):264-74. Epub 2006 Jan 4.

PMID:
16386893
35.

Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract.

Geddert H, Kiel S, Zotz RB, Zhang J, Willers R, Gabbert HE, Sarbia M.

J Cancer Res Clin Oncol. 2005 Dec;131(12):803-8. Epub 2005 Nov 15.

PMID:
16163549
36.

Adrenal pheochromocytoma with contralateral cortisol-producing adrenal adenoma: diagnostic and therapeutic management.

Wolf A, Willenberg HS, Cupisti K, Schott M, Geddert H, Raffel A, Bornstein SR, Scherbaum WA, Knoefel WT.

Horm Metab Res. 2005 Jun;37(6):391-5.

PMID:
16001333
37.

Esophageal (Barrett's) adenocarcinoma is not associated with Epstein-Barr virus infection: an analysis of 162 cases.

Sarbia M, zur Hausen A, Feith M, Geddert H, von Rahden BH, Langer R, von Weyhern C, Siewert JR, Höfler H, Stein HJ.

Int J Cancer. 2005 Nov 20;117(4):698-700. No abstract available.

38.

Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer.

Grote HJ, Schmiemann V, Geddert H, Rohr UP, Kappes R, Gabbert HE, Böcking A.

Int J Cancer. 2005 Sep 20;116(5):720-5.

39.

Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract.

Sarbia M, Geddert H, Kiel S, Kandemin Y, Schulz WA, Vossen S, Zotz RD, Willers R, Baldus SE, Schneider PM, Gabbert HE.

Scand J Gastroenterol. 2005 Jan;40(1):109-11. No abstract available.

PMID:
15841723
40.

Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Geddert H, Pflugfelder L, Bruns I, Neukirch J, Rohrbeck A, Grote HJ, Steidl U, Fenk R, Opalka B, Gabbert HE, Kronenwett R, Haas R.

Clin Cancer Res. 2005 Jan 1;11(1):180-5.

41.

Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Pflugfelder L, Geddert H, Müller W, Steidl U, Fenk R, Gräf T, Schott M, Thiele KP, Gabbert HE, Germing U, Kronenwett R, Haas R.

Int J Cancer. 2004 Aug 20;111(2):259-63.

42.

Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract.

Sarbia M, Geddert H, Klump B, Kiel S, Iskender E, Gabbert HE.

Int J Cancer. 2004 Aug 20;111(2):224-8.

43.

Correlation of hMLH1 and HPP1 hypermethylation in gastric, but not in esophageal and cardiac adenocarcinoma.

Geddert H, Kiel S, Iskender E, Florl AR, Krieg T, Vossen S, Gabbert HE, Sarbia M.

Int J Cancer. 2004 Jun 10;110(2):208-11.

44.

The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.

Geddert H, Kiel S, Heep HJ, Gabbert HE, Sarbia M.

Hum Pathol. 2003 Sep;34(9):850-6.

PMID:
14562279
45.

Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.

Sarbia M, Bitzer M, Siegel D, Ross D, Schulz WA, Zotz RB, Kiel S, Geddert H, Kandemir Y, Walter A, Willers R, Gabbert HE.

Int J Cancer. 2003 Nov 10;107(3):381-6.

46.

NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China.

Zhang JH, Li Y, Wang R, Geddert H, Guo W, Wen DG, Chen ZF, Wei LZ, Kuang G, He M, Zhang LW, Wu ML, Wang SJ.

World J Gastroenterol. 2003 Jul;9(7):1390-3.

47.

[Histopathological diagnosis of Barrett's mucosa and associated neoplasias. Results of a consensus conference of the Working Group for "Gastroenterological Pathology of the German Society for Pathology" on 22 September 2001].

Faller G, Berndt R, Borchard F, Ell C, Fuchs KH, Geddert H, Gossner L, Günther T, Kirchner T, Koch HK, Langner C, Lüttges J, May A, Müller S, Oberhuber G, Seitz G, Stolte M, Tannapfel A, Vieth M, Walch A, Rüschoff J; Working Group for Gastroenterological Pathology, German Society for Pathology.

Pathologe. 2003 Feb;24(1):9-14. Epub 2003 Jan 15. German.

PMID:
12601473
48.

Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions.

Geddert H, Zeriouh M, Wolter M, Heise JW, Gabbert HE, Sarbia M.

Am J Clin Pathol. 2002 Jul;118(1):60-6.

PMID:
12109857
49.

Expression of cyclin B1 in the metaplasia-dysplasia-carcinoma sequence of Barrett esophagus.

Geddert H, Heep HJ, Gabbert HE, Sarbia M.

Cancer. 2002 Jan 1;94(1):212-8.

Supplemental Content

Loading ...
Support Center